A detailed history of Peregrine Capital Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 294,258 shares of OGN stock, worth $4.35 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
294,258
Previous 389,650 24.48%
Holding current value
$4.35 Million
Previous $8.07 Million 30.2%
% of portfolio
0.18%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$18.65 - $23.03 $1.78 Million - $2.2 Million
-95,392 Reduced 24.48%
294,258 $5.63 Million
Q2 2024

Jul 29, 2024

SELL
$17.45 - $21.96 $23,400 - $29,448
-1,341 Reduced 0.34%
389,650 $8.07 Million
Q1 2024

Apr 26, 2024

BUY
$13.78 - $18.8 $5.39 Million - $7.35 Million
390,991 New
390,991 $7.35 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.